Latest News

Abbott gains US FDA nod to treat non-surgical back pain with...

Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic...

Features

The new standard for SCS therapy—neural activation measurement, targeting and maintenance

Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...

Spinal News International’s top 10 most popular stories of February 2023

Research looking at the Vertebral Bone Quality Score as a predictor of pedicle screw loosening was our most viewed story in February, followed by...

Videos

 Michael Fehlings (Toronto, Canada) talks to Spinal News International at DWG-Kongress (7–9 December 2022; Berlin, Germany) about the “dramatic shift” over the past 25 years in the management and outcomes of spinal cord injury (SCI) patients. “Time is spine” is an important...

Daniel Riew

Alex Vaccaro

Margareta Nordin in spine care

Margareta Nordin